Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Carlsmed (CARL) Revenue (2024 - 2025)

Carlsmed (CARL) has disclosed Revenue for 2 consecutive years, with $13.1 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Revenue rose 98.39% year-over-year to $13.1 million, compared with a TTM value of $34.6 million through Dec 2025, changed N/A, and an annual FY2025 reading of $50.5 million, up 85.94% over the prior year.
  • Revenue was $13.1 million for Q3 2025 at Carlsmed, up from $12.1 million in the prior quarter.
  • Across five years, Revenue topped out at $13.1 million in Q3 2025 and bottomed at -$325000.0 in Q2 2024.